Literature DB >> 26120184

Scleromyxedema: An Atypical Case.

Emy Thomas1, Anisha George1, Divya Deodhar2, Mary John2.   

Abstract

Scleromyxedema is a rare, chronic and persistent idiopathic disorder characterized by a generalized papular eruption due to dermal mucin deposition with an increase in dermal collagen. Patients usually have associated paraproteinemia. We describe the case of a 59-year-old gentleman with features of scleromyxedema, who had severe pruritus, scalp involvement, unrestricted mobility and associated peripheral eosinophilia, but no monoclonal gammopathy.

Entities:  

Keywords:  Eosinophilia; papular mucinosis; scleromyxedema

Year:  2015        PMID: 26120184      PMCID: PMC4458971          DOI: 10.4103/0019-5154.156456

Source DB:  PubMed          Journal:  Indian J Dermatol        ISSN: 0019-5154            Impact factor:   1.494


  10 in total

Review 1.  Scleromyxedema revisited.

Authors:  John J Pomann; Earl J Rudner
Journal:  Int J Dermatol       Date:  2003-01       Impact factor: 2.736

2.  Steady remission of scleromyxedema 3 years after autologous stem cell transplantation: an in vivo and in vitro study.

Authors:  Isabel Illa; Carolina de la Torre; Ricardo Rojas-Garcia; Antoni Altes; Rafael Blesa; Jordi Sierra; Eduard Gallardo
Journal:  Blood       Date:  2006-07-15       Impact factor: 22.113

3.  Scleromyxedema.

Authors:  A O Harris; A R Altman; J A Tschen; J E Wolf
Journal:  Int J Dermatol       Date:  1989-12       Impact factor: 2.736

4.  Scleromyxedema: role of high-dose melphalan with autologous stem cell transplantation.

Authors:  Michele L Donato; Adrienne M Feasel; Donna M Weber; Victor G Prieto; Sergio A Giralt; Richard E Champlin; Madeleine Duvic
Journal:  Blood       Date:  2005-09-22       Impact factor: 22.113

Review 5.  Updated classification of papular mucinosis, lichen myxedematosus, and scleromyxedema.

Authors:  F Rongioletti; A Rebora
Journal:  J Am Acad Dermatol       Date:  2001-02       Impact factor: 11.527

6.  Managing scleromyxedema with intravenous immunoglobulin: acute worsening of scleromyxedema with biclonal gammopathy.

Authors:  I Manousaridis; C Loeser; S Goerdt; J C Hassel
Journal:  Acta Dermatovenerol Alp Pannonica Adriat       Date:  2010-12

7.  Papular mucinosis with myopathy, arthritis, and eosinophilia. A histopathologic study.

Authors:  L P McAdam; C M Pearson; W H Pitts; L Sadoff; M A Verity
Journal:  Arthritis Rheum       Date:  1977-05

8.  Scleromyxedema.

Authors:  A M Dinneen; C H Dicken
Journal:  J Am Acad Dermatol       Date:  1995-07       Impact factor: 11.527

9.  Arndt Gottron scleromyxedema: successful response to treatment with steroid minipulse and methotrexate.

Authors:  Vandana Mehta; C Balachandran; Raghavendra Rao
Journal:  Indian J Dermatol       Date:  2009       Impact factor: 1.494

10.  Scleromyxedema: a case report and review of the literature.

Authors:  Mohamed Allam; Mohamed Ghozzi
Journal:  Case Rep Dermatol       Date:  2013-06-11
  10 in total
  3 in total

1.  Authors' Reply.

Authors:  Emy Thomas; Anisha George; Divya Deodhar; Mary John
Journal:  Indian J Dermatol       Date:  2016 Jan-Feb       Impact factor: 1.494

Review 2.  Knuckle lesions in inherited and acquired disorders.

Authors:  Keshavmurthy A Adya; Arun C Inamadar; Aparna Palit; Ragunatha Shivanna
Journal:  Indian Dermatol Online J       Date:  2021-11-22

3.  Lichen Myxedematosus: Strict Classification and Diagnostic Criteria are Still Lacking.

Authors:  Ahmad Nofal; Rania Alakad; Hala Amer; Eman Nofal
Journal:  Indian J Dermatol       Date:  2016 Jan-Feb       Impact factor: 1.494

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.